Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,673.00
Bid: 1,674.00
Ask: 1,675.00
Change: 3.00 (0.18%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 12th Nov 2013 09:20

Accesso: Canaccord Genuity raises target price from 680p to 770p and keeps a buy recommendation.Andor Technology: FinnCap places both its target price (prev.: 390p) and its hold recommendation under review.Babcock International: Jefferies increases target price from 1250p to 1600p retaining a buy recommendation. Investec places its target price (prev.: 1175p) under review, while keeping its add rating.Balfour Beatty: UBS raises target price from 220p to 245p, while downgrading from neutral to sell.British Sky Broadcasting: Alphavalue shifts target price from 1055.2p to 1056.7p and upgrades from add to buy. Credit Suisse reduces target price from 810p to 700p downgrading to underperform.BTG: Investec places its target price (prev.: 472p) under review, while its buy recommendation is kept.Catlin Group: Canaccord Genuity moves target price from 540p to 550p and maintains a buy recommendation.Central Asia Materials: FinnCap initiates with a target price of 222p and a buy recommendation. Canaccord Genuity takes target price from 210p to 245p and stays with its buy recommendation.Chesnara: Canaccord Genuity moves target price from 290p to 300p, while downgrading from buy to hold.Cobham: Deutsche Bank lowers target price from 275p to 270p and maintains a hold recommendation. JP Morgan cuts target price from 310p to 270p reiterating a neutral rating. UBS lowers target price from 305p to 290p leaving its buy recommendation unchanged.Coca-Cola HBC: Goldman Sachs reduces target price from 2100p to 2000p and retains a neutral rating.Craneware: Investec raises target price from 365p to 530p and maintains a buy recommendation.Cropper (James): Westhouse Securities increases target price from 350p to 450p, while downgrading to add.F&C Asset Management: Barclays initiates with a target price of 90p and an underweight rating.GlaxoSmithKline: Panmure Gordon reduces target price from 1850p to 1750p and downgrades from buy to hold.Halfords Group: Deutsche Bank raises target price from 330p to 410p, but still recommends selling.Hunting: FinnCap cuts target price from 900p to 840p, while its hold recommendation is kept.Inmarsat: Alphavalue shifts target price from 729.7p to 732.6p upgrading from reduce to add.Ithaca Energy: Liberum Capital moves target price from 210p to 207p, while staying with its buy recommendation.Lonmin: Deutsche Bank increases target price from 315p to 390p and stays with its hold recommendation. Citi ups target price from 420p to 453p and reiterates a buy recommendation. HSBC raises target price from 485p to 512p leaving its overweight rating unaltered. JP Morgan takes target price from 400p to 430p and keeps an overweight rating.Morgan Advanced Materials: Jefferies lowers target price from 345p to 340p staying with its buy recommendation. JP Morgan moves target price from 335p to 330p, while leaving its overweight rating unchanged. Investec reduces target price from 410p to 390p, while its buy recommendation remains unchanged.Rentokil: Jefferies raises target price from 104p to 116p and keeps a hold recommendation.Rightmove: Panmure Gordon takes target price from 3000p to 3130p maintaining a buy recommendation.Royal Bank of Scotland: Nomura ups target price from 270p to 285p maintaining a reduce rating.RSA Insurance Group: Deutsche Bank shifts target price from 117p to 115p and retains a hold recommendation. Nomura lowers target price fromk 120p to 113p reiterating a neutral rating. JP Morgan cuts target price from 140p to 126p and downgrades to neutral.Shire: Societe Generale increases target price from 3270p to 3615p reiterating a buy recommendation.Smith (WH): Deutsche Bank raises target price from 960p to 1075p maintaining a buy recommendation. UBS increases target price from 750p to 1000p.Speedy Hire: Panmure Gordon shifts target price from 73.6p to 75p and stays with its hold recommendation.Synergy Health: Investec moves target price from 1140p to 1165p and reiterates a buy recommendation.Trifast: N+1 Singer ups target price from 68p to 89p and leaves its buy recommendation unchanged. FinnCap takes target price from 66p to 91p retaining a buy recommendation. Westhouse Securities places both its target price (prev.: 80p) and its buy recommendation under review.Vodafone Group: Espirito Santo ups target price from 215p to 230p and retains a neutral rating.Workspace Group: Liberum Capital takes target price from 546p to 584p and maintains a buy recommendation. Investec ups target price from 500p to 560p retaining a buy recommendation.
More News
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.